March 17, 2023
Andy Hsieh, PhD, is a biotechnology analyst at William Blair. Hsieh is joining the QB3-Berkeley Professionals in Residence (PIR) program on Friday, March 24, 2023. UC Berkeley and Lawrence Berkeley Lab graduate students and postdocs may register for Hsieh’s PIR events here. Hsieh spoke with graduate student Samvardhini Sridharan about his transition into the financial…
January 11, 2023
Miki Yamamoto, PhD, is the vice president and head of regulatory affairs at Arrivent Biopharma. Yamamoto is joining the QB3-Berkeley Professionals in Residence (PIR) program on February 9th 2023. UC Berkeley and LBL trainees may register for Yamamoto’s events here. Yamamoto spoke with graduate student Anneliese Gest about her journey in regulatory affairs. Anneliese Gest:…
November 15, 2022
Katja Brose, PhD, is a science program officer at the Chan Zuckerberg Initiative (CZI). Brose is joining the QB3-Berkeley Professionals in Residence (PIR) program on January 26th, 2023. UC Berkeley trainees may register for Brose’s PIR events here. Brose spoke with graduate student Samvardhini Sridharan about her career and the opportunities she’s had to wear…
April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to postdoctoral researcher Elisabeth Gill about his trajectory from academic research to the biotech entrepreneurship ecosystem working in a biotech start-up, consulting, within the business development…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In an interview with graduate student Leah Gulyas, Day traced his path to entrepreneurship from growing up in Kansas with the goal of pursuing medicine to…
February 23, 2022
While graduate students in the College of Chemistry have long been leading DEI efforts and initiatives to improve the unit’s climate, a new program provides more support and compensation for their work. Academic institutions have recently shifted significantly toward focusing on diversity, equity, and inclusion (DEI). Many departments and colleges at UC Berkeley have shown…
January 24, 2022
Christopher Hann-Soden discusses the breadth of services offered at UC Berkeley’s QB3 Genomics Core Facility. The QB3 Genomics core research facility is an umbrella term for three separate UC Berkeley research facilities devoted to different stages of high throughput sequencing and genomics experiments. Hundreds of researchers turn to QB3 Genomics including almost all researchers who…
January 18, 2022
UC Berkeley research strives to understand the cell’s complex recycling program and how we can use it to treat diseases. Our bodies are composed of trillions of cells—each one equipped with a microscopic recycling center known as the ubiquitin-proteasome system, or UPS. When proteins inside the cell need to be removed, the UPS recognizes, marks,…